Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)

NCT01159847 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: sitagliptin
DRUG: Insulin

Sponsor

European Foundation for the Study of Diabetes

Collaborators

[object Object]
[object Object]